Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s to acquire select business divisions of Wockhardt
>>
Dr. Reddy's arm, Curis amend collaboration pact for development, commercialization of CA-170
>>
Dr. Reddy’s Laboratories gains on launching Trientine Hydrochloride Capsules in US market
>>
Dr. Reddy’s Laboratories launches Trientine Hydrochloride Capsules in US market
>>
Dr. Reddys Laboratories informs about company updates
>>
Dr. Reddy's Laboratories informs about completion of auditing
>>
USFDA completes audit at Dr. Reddy's Lab’s Srikakulam plant
>>
Dr. Reddys shines despite reporting consolidated net loss of Rs 538 crore in Q3
>>
Dr. Reddys reports consolidated net loss of Rs 538 crore in Q3
>>
Dr. Reddy’s gets shareholders' nod to amalgamate Dr Reddy’s Holdings with itself
<<
<
61
62
63
...145
>
>>